Methylprednisolone Dose in Bell's Palsy
For Bell's palsy in adults ≥16 years, use prednisolone (NOT methylprednisolone as first-line) at 60 mg daily for 5 days followed by a 5-day taper, OR prednisolone 50 mg daily for 10 days, initiated within 72 hours of symptom onset. 1
Preferred Corticosteroid and Dosing
The American Academy of Otolaryngology-Head and Neck Surgery clinical practice guideline provides a strong recommendation for oral steroids based on high-quality RCTs showing significant improvement in facial nerve recovery 1. The guideline specifically references prednisolone (not methylprednisolone) as the studied and recommended agent, with two validated regimens:
- Prednisolone 60 mg daily for 5 days, then taper over 5 days (10-day total course)
- Prednisolone 50 mg daily for 10 days (no taper)
Both regimens demonstrated 83-94.4% recovery rates at 3-9 months versus 63.6-81.6% with placebo 1.
If Methylprednisolone Must Be Used
While prednisolone is the evidence-based choice, if methylprednisolone is specifically required, convert using the equivalency: 4 mg methylprednisolone = 5 mg prednisolone 2. This translates to:
- Methylprednisolone 48 mg daily for 5 days, then taper over 5 days, OR
- Methylprednisolone 40 mg daily for 10 days
Alternative IV Methylprednisolone Approach
Recent research suggests single-dose IV methylprednisolone 500 mg shows equivalent 3-month recovery rates to 10-day oral prednisolone (80% vs 78.33%) 3. A 2024 meta-analysis found IV methylprednisolone superior to oral prednisolone for 1-month recovery (particularly in grade 4 palsy), though no difference at 3 months 4. However, this is NOT guideline-recommended and should be reserved for patients unable to take oral medications.
Another study used IV methylprednisolone 2 mg/kg/day for 7 days with 92% good outcomes 5, but this lacks guideline support.
Critical Timing and Patient Selection
- Initiate within 72 hours of symptom onset - benefit after 72 hours is unclear 1
- Age ≥16 years - evidence in children is insufficient and spontaneous recovery rates are higher 1
- Exclude atypical features requiring imaging: recurrent paralysis same side, isolated branch involvement, other cranial nerve involvement, or no recovery after 3 months 1
Common Pitfalls to Avoid
- Do NOT use antiviral monotherapy - antivirals alone are no better than placebo 1
- Do NOT use methylprednisolone as first-line - prednisolone has the RCT evidence base
- Do NOT delay treatment - efficacy drops significantly after 72 hours
- Do NOT abruptly stop after long-term use - taper gradually 2
Monitoring Considerations
The FDA label emphasizes dosage must be individualized based on disease severity and patient response 2. For Bell's palsy specifically, the guideline-recommended fixed regimens eliminate this variability. Monitor for typical corticosteroid adverse effects, though the short 10-day course minimizes HPA axis suppression risk 2.